Hosted by the Chengdu High-tech Medical Association, the seminar themed "Targeted Therapy & Immunotherapy Integration · Breaking the Dilemma Together: Immunotherapy 2.0 Era - A Special Session on Lung Cancer" was successfully held on July 6, 2025.The event brought together multidisciplinary experts from departments including respiratory medicine, oncology, thoracic surgery, pathology and medical imaging across multiple hospitals. Focusing on the standardized diagnosis and treatment of lung cancer, adverse reaction management, and cutting-edge research advances, the seminar conducted in-depth online exchanges. It fully demonstrated the core value of multidisciplinary collaboration in the whole-course management of lung cancer, and effectively promoted the improvement of regional diagnosis and treatment standards as well as the formation of academic consensus.